Project Funding People Map

◥

AltAwardCode: 5UG1CA189867-03

Total PIs: 1 / Total Collabs: 130

Name	Type	Institution	Region	Location
Bruner, Deborah Watkins	Principal Investigator	NRG Oncology Foundation, Inc.	North America	Philadelphia, PA, US
Allen, Aaron	Collaborator	Rabin Medical Center	Middle East & North Africa	Petah Tikva, IL
Arranz-Arija, Jose Angel	Collaborator	Hospital General Universitario Gregorio Marañón	Europe & Central Asia	Madrid, ES
Balogh, Alexander	Collaborator	Foothills Medical Centre	North America	Calgary, AB, CA
Balogh, Alexander	Collaborator	Alberta Health Services	North America	Calgary, AB, CA
Beadle, Geoffrey Francis	Collaborator	Royal Brisbane and Women's Hospital	Australia & New Zealand	Brisbane, QLD, AU
Beitler, Jonathan	Collaborator	National University Hospital	East Asia & Pacific	Singapore, SG
Boadle, David John	Collaborator	Royal Hobart Hospital	Australia & New Zealand	Hobart, TAS, AU
Bover, Isabel	Collaborator	Hospital Son Llatzer	Europe & Central Asia	Palma, ES
Boyce, Adam Richard	Collaborator	Lismore Base Hospital	Australia & New Zealand	Lismore, AU
Briscoe, Karen P	Collaborator	Mid North Coast Cancer Institute	Australia & New Zealand	Coffs Harbour, AU
Chabot, Pierre	Collaborator	Hôpital Maisonneuve-Rosemont	North America	Montréal, QC, CA
Chafe, Susan	Collaborator	BC Cancer Agency - Sindi Ahluwalia Hawkins Centre for the Southern Interior	North America	Kelowna, BC, CA
Chafe, Susan	Collaborator	Alberta Health Services	North America	Calgary, AB, CA
Corn, Benjamin	Collaborator	Tel Aviv Sourasky Medical Center	Middle East & North Africa	Tel Aviv, IL
Covens, Allan	Collaborator	Sunnybrook Health Science Centre	North America	Toronto, ON, CA
Covens, Allan	Collaborator	Women's College Hospital	North America	Toronto, ON, CA
Cronk, Michelle Frances	Collaborator	Nambour General Hospital	Australia & New Zealand	Nambour, AU
D'Souza, David Paul	Collaborator	London Health Sciences Centre	North America	London, ON, CA
D'Souza, David Paul	Collaborator	BC Cancer Agency - Vancouver Island Centre	North America	Victoria, BC, CA
D'Souza, David Paul	Collaborator	Saint John Regional Hospital	North America	Saint John, NB, CA
D'Souza, David Paul	Collaborator	Windsor Regional Hospital	North America	Windsor, ON, CA
D'Souza, David Paul	Collaborator	Grand River Hospital	North America	Kitchener, ON, CA
D'Souza, David Paul	Collaborator	Thunder Bay Regional Health Sciences Centre	North America	Thunder Bay, ON, CA
Dewar, Joanna Mary	Collaborator	Sir Charles Gairdner Hospital	Australia & New Zealand	Perth, WA, AU
El-Gayed, Ali	Collaborator	Saskatoon Cancer Centre	North America	Saskatoon, SK, CA
Falkson, Conrad	Collaborator	Kingston General Hospital	North America	Kingston, ON, CA
Feigenberg, Steven	Collaborator	Tata Memorial Hospital	South Asia	Mumbai, IN
Forbes, John Frederick	Collaborator	Calvary Mater Newcastle Hospital	Australia & New Zealand	Waratah, AU
Fuijwara, Keiichi	Collaborator	Tottori University	East Asia & Pacific	Tottori-shi, JP
Fuijwara, Keiichi	Collaborator	Hyogo Prefectural Cancer Center	East Asia & Pacific	Akashi, JP
Fuijwara, Keiichi	Collaborator	Tohoku University	East Asia & Pacific	Sendai, Miyagi, JP
Fuijwara, Keiichi	Collaborator	National Hospital Organization Kyushu Cancer Center	East Asia & Pacific	Fukuoka, 40, JP
Fuijwara, Keiichi	Collaborator	Jikei University	East Asia & Pacific	Minato, 13, JP
Fuijwara, Keiichi	Collaborator	Iwate Medical University	East Asia & Pacific	Morioka, JP
Fuijwara, Keiichi	Collaborator	Saitama International Medical Center	East Asia & Pacific	Hidaka, Saitama, JP
Fuijwara, Keiichi	Collaborator	Kinki Health Welfare University	East Asia & Pacific	Kanzakimachi-kanzaki, JP
Fuijwara, Keiichi	Collaborator	Keio University	East Asia & Pacific	Shinjuku, Tokyo, JP
Fuijwara, Keiichi	Collaborator	Hokkaido University Hospital	East Asia & Pacific	Sapporo, 1, JP
Fuijwara, Keiichi	Collaborator	Kagoshima City Hospital	East Asia & Pacific	Kagoshima, JP
Fuijwara, Keiichi	Collaborator	Hiroshima University Hospital	East Asia & Pacific	Hiroshima, JP
Fuijwara, Keiichi	Collaborator	University of the Ryukyus	East Asia & Pacific	Nishihara, JP
Fuijwara, Keiichi	Collaborator	Niigata University Medical and Dental Hospital	East Asia & Pacific	Niigata, JP
Fuijwara, Keiichi	Collaborator	Shizuoka Cancer Center	East Asia & Pacific	Sunto, Shizuoka, JP
Fuijwara, Keiichi	Collaborator	Kure Medical Center	East Asia & Pacific	Kure, JP
Fuijwara, Keiichi	Collaborator	Shikoku Cancer Center	East Asia & Pacific	Matsuyama, 38, JP
Goel, Rakesh	Collaborator	Ottawa Hospital	North America	Ottawa, ON, CA
Goel, Rakesh	Collaborator	Irving Greenberg Family Cancer Centre	North America	Ottawa, ON, CA
Grenier, Debjanie	Collaborator	CancerCare Manitoba	North America	Winnipeg, MB, CA
Im, Young-Hyuck	Collaborator	Samsung Medical Center	East Asia & Pacific	Seoul, KR
Kuerer, Henry	Collaborator	Chang Gung Memorial Hospital	East Asia & Pacific	Taipei, TW
Kuerer, Henry	Collaborator	National Taiwan University Hospital	East Asia & Pacific	Taipei, TW
Kuerer, Henry	Collaborator	Queen Mary Hospital	East Asia & Pacific	Hong Kong, HK
Kuerer, Henry	Collaborator	King Faisal Specialist Hospital & Research Centre	Middle East & North Africa	Riyadh, SA
Kuerer, Henry	Collaborator	Chonnam National University Hwasun Hospital	East Asia & Pacific	Hwasun, KR
Kuerer, Henry	Collaborator	Yonsei University	East Asia & Pacific	Seoul, KR
Kuerer, Henry	Collaborator	Chinese University of Hong Kong	East Asia & Pacific	Hong Kong, CN
Kuerer, Henry	Collaborator	Instituto Nacional de Cancerología	Latin America & Caribbean	Tlalpan, MX
Kuerer, Henry	Collaborator	Kantonsspital Aarau	Europe & Central Asia	Aarau, CH
Kuerer, Henry	Collaborator	National Cancer Centre Singapore	East Asia & Pacific	Singapore, SG
Kuper-Hommel, Marion	Collaborator	Waikato Hospital	Australia & New Zealand	Hamilton, NZ
Lombard, Janine Margaret	Collaborator	Newcastle Private Hospital	Australia & New Zealand	New Lambton, AU
Lukka, Himu	Collaborator	Dr. H. Bliss Murphy Cancer Centre	North America	St. John's, NL, CA
Lukka, Himu	Collaborator	Queen Elizabeth II Health Sciences Centre	North America	Halifax, NS, CA
Lukka, Himu	Collaborator	Prince Edward Island Cancer Treatment Centre	North America	Charlottetown, PE, CA
Lukka, Himu	Collaborator	St. Joseph's Hospital	North America	Hamilton, ON, CA
Lukka, Himu	Collaborator	Niagara Health System (NHS)	North America	St. Catharines, ON, CA
Lukka, Himu	Collaborator	Juravinski Cancer Centre	North America	Hamilton, ON, CA
Margolese, Richard	Collaborator	Jewish General Hospital	North America	Montréal, QC, CA
Moulton, Brian	Collaborator	Cork University Hospital	Europe & Central Asia	Cork, IE
Moulton, Brian	Collaborator	Mid-Western Regional Hospital	Europe & Central Asia	Nenagh, IE
Moulton, Brian	Collaborator	St. Luke's Hospital	Europe & Central Asia	Dublin, IE
Moulton, Brian	Collaborator	South Infirmary Victoria University Hospital	Europe & Central Asia	Cork, IE
Moulton, Brian	Collaborator	Tallaght Hospital	Europe & Central Asia	Dublin, IE
Moulton, Brian	Collaborator	Beaumont Hospital	Europe & Central Asia	Dublin, IE
Moulton, Brian	Collaborator	St. James's Hospital	Europe & Central Asia	Dublin, IE
Moulton, Brian	Collaborator	Sligo General Hospital	Europe & Central Asia	Sligo, IE
Moulton, Brian	Collaborator	St. Vincent's University Hospital	Europe & Central Asia	Dublin, IE
Moulton, Brian	Collaborator	Ireland Cooperative Oncology Research Group	Europe & Central Asia	Dublin, IE
Moulton, Brian	Collaborator	UPMC Whitfield Cancer Centre	Europe & Central Asia	Waterford, IE
Moulton, Brian	Collaborator	Letterkenny General Hospital	Europe & Central Asia	Letterkenny, IE
Moulton, Brian	Collaborator	Mater Misericordiae University Hospital	Europe & Central Asia	Dublin, IE
Moulton, Brian	Collaborator	Beacon Hospital	Europe & Central Asia	Dublin, IE
Moulton, Brian	Collaborator	University Hospital Galway	Europe & Central Asia	Galway, IE
Moulton, Brian	Collaborator	University Hospital Waterford	Europe & Central Asia	Waterford, IE
Moulton, Brian	Collaborator	Mater Private Hospital	Australia & New Zealand	Brisbane, QLD, AU
Moulton, Brian	Collaborator	Midland Regional Hospital at Tullamore	Europe & Central Asia	Tullamore, IE
Na, Joo Nyun	Collaborator	Seoul National University Bundang Hospital	East Asia & Pacific	Seoul, KR
Nam, Joo Hyun	Collaborator	Seoul National University Hospital	East Asia & Pacific	Seoul, KR
Nam, Joo Hyun	Collaborator	Ajou University Hospital	East Asia & Pacific	Suwon, KR
Nam, Joo Nyun	Collaborator	Keimyung University Dongsan Medical Center	East Asia & Pacific	Daegu, KR
Nam, Joo Nyun	Collaborator	Inha University Hospital	East Asia & Pacific	Incheon, KR
Nam, Joo Nyun	Collaborator	CHA Bundang Medical Center	East Asia & Pacific	Seongnam-si, KR
Nam, Joo Nyun	Collaborator	Catholic University of Korea	East Asia & Pacific	Seoul, KR
Nam, Joo Nyun	Collaborator	Ewha Womans University	East Asia & Pacific	Seoul, KR
Nam, Joo Nyun	Collaborator	Asan Medical Center	East Asia & Pacific	Seoul, KR
Nam, Joo Nyun	Collaborator	National Cancer Center	East Asia & Pacific	Goyang-si, KR
Nam, Joo-Hyun	Collaborator	Gangnam Severance Hospital	East Asia & Pacific	Seoul, KR
Oaknin, Ana	Collaborator	Hospital Universitari Vall d'Hebron	Europe & Central Asia	Barcelona, ES
Prchal, Jaroslav	Collaborator	St Mary's Hospital	North America	Montréal, QC, CA
Redondo, Andres	Collaborator	Hospital Universitario La Paz	Europe & Central Asia	Madrid, ES
Roach, Mack	Collaborator	Peter MacCallum Cancer Centre	Australia & New Zealand	Melbourne, VIC, AU
Roach III, Mack	Collaborator	Hospital Universitario de La Princesa	Europe & Central Asia	Madrid, ES
Robidoux, Andre	Collaborator	Centre Hospitalier de l’Université de Montréal	North America	Montréal, QC, CA
Robidoux, Andre	Collaborator	Hôpital Notre-Dame	North America	Montréal, QC, CA
Robidoux, Andre	Collaborator	Hôpital Saint-Luc	North America	Montréal, QC, CA
Robidoux, Andre	Collaborator	Hôpital de la Cité-de-la-Santé	North America	Laval, QC, CA
Sadikov, Evgeny	Collaborator	Saskatchewan Cancer Agency	North America	Regina, SK, CA
Schink, Julian	Collaborator	Rambam Health Care Campus	Middle East & North Africa	Haifa, IL
Schink, Julian	Collaborator	Weston Park Hospital	Europe & Central Asia	Sheffield, ENG, UK
Schink, Julian	Collaborator	Charing Cross Hospital	Europe & Central Asia	Hammersmith, ENG, UK
Schink, Julian	Collaborator	Royal Hallamshire Hospital	Europe & Central Asia	Sheffield, ENG, UK
Shibata, Henry	Collaborator	Royal Victoria Hospital	North America	Montréal, QC, CA
Sigurdson, Elin	Collaborator	Royal North Shore Hospital	Australia & New Zealand	St Leonards, NSW, AU
Souhami, Luis	Collaborator	McGill University Health Centre	North America	Montréal, QC, CA
Souhami, Luis	Collaborator	Centre Hospitalier Universitaire de Sherbrooke	North America	Sherbrooke, QC, CA
Sun, Alexander	Collaborator	Tuen Mun Hospital	East Asia & Pacific	Hong Kong, CN
Sun, Alexander	Collaborator	Pamela Youde Nethersole Eastern Hospital	East Asia & Pacific	Hong Kong, HK
Sun, Alexander	Collaborator	Southlake Regional Health Center	North America	Newmarket, ON, CA
Sun, Alexander	Collaborator	Princess Margaret Cancer Centre - University Health Network	North America	Toronto, ON, CA
Tewari, Krishnansu	Collaborator	Jagiellonian University	Europe & Central Asia	Krakow, PL
Tewari, Krishnansu	Collaborator	Medical University of Bialystok	Europe & Central Asia	Bialystok, PL
Tewari, Krishnansu	Collaborator	Tawam Hospital	Middle East & North Africa	Al Ain, AE
Tewari, Krishnansu	Collaborator	European Institute of Oncology	Europe & Central Asia	Milano, IT
Thirlwell, Michael	Collaborator	Montreal General Hospital	North America	Montréal, QC, CA
Trotti, Andy	Collaborator	Maastro Clinic	Europe & Central Asia	Maastricht, NL
Underhill, Craig Richard	Collaborator	Border Medical Oncology	Australia & New Zealand	Wodonga , AU
Vigneault, Eric	Collaborator	Hôpital du Saint-Sacrement	North America	Québec, QC, CA
Vigneault, Eric	Collaborator	Hôtel-Dieu de Québec	North America	Québec, QC, CA
Werner-Wasik, Maria	Collaborator	Sheba Medical Center	Middle East & North Africa	Ramat Gan, IL
Werner-Waski, Maria	Collaborator	Fudan University Shanghai Cancer Center	East Asia & Pacific	Shanghai, CN

Single-funder organizations
Partner	Caveat
ACS	Dollar amounts found in the ICRP database are different than what is reported in the American Cancer Society's Annual Report. The dollar amounts spent on research reported in audited reports include operating expenses of the Research Department. Additionally, the dollar amounts also exclude all grants that were cancelled after being awarded, but include money that was returned from grants cancelled in the current year that were awarded in previous years. The dollar amounts reported in the database are unaudited and include grants awarded each fiscal year, exclusive of grants that cancelled before activation.
CBCRP	The California Breast Cancer Research Program grants are awarded only to individuals or institutions in California. Grants to the University of California receive only direct funds, while grants to other institutions also receive indirect costs (overhead) at 25% or the federally negotiated rate. Collaborative awards are counted in graphs and tables by the number of co-Principal Investigators rather than the number of projects.
Komen	Dollar amounts found in the ICRP database are different than what is reported on Komen\'s website or in Komen\'s Annual Report for the following reasons: Komen commits all funds necessary to support a research grant in the year it is awarded. Therefore, Komen\'s website reports on the full amount of each grant in the year it is initiated, while the ICRP data is annualized, as described. Komen funds research grants to our Scientific Advisors (Scientific Advisory Board members and Komen Scholars) and also provides discretionary funding of research-related projects that are not traditional research grants (e.g. support of the Komen Tissue Bank, ASCO and AACR meeting support). These are included in the overall Research Program spending, as reported in our Annual Report and on our website, but are not included in the ICRP database.
NIH	NIH projects in NIH Reporter assigned to the Spend Category ‘cancer’ are included in the ICRP database from FY2005 onwards. A small number of projects are excluded if essential information is missing (primarily Project title, Institution). Previous years’ data were drawn from the NFRP and may be incomplete. Starting in FY2007 NCI reports funding supplements, etc., for each grant separately instead of including them in the main project, therefore the number of projects may differ significantly from those of previous years. Projects with a cost of $0 include those that were a no-cost extension of the grant or when funding was provided by another NIH institute or center for that FY. NCI dollars in the ICRP database are drawn from NIH reporter and may not match dollars from other NCI-only databases.
Worldwide Cancer Research	Worldwide Cancer Research is unique in that the majority of our funding is awarded to researchers in countries outside the UK. Like many UK research charities, Worldwide Cancer Research only funds the direct costs of research. This creates significant problems in making quantitative comparisons between our funding and that provided by some of the other agencies in the ICRP, which fund both the direct and indirect costs (often called overheads) of research.

UK Organizations that are part of NCRI
Partner	Caveat
NCRI (GENERIC)	NCRI submits data to ICRP on behalf of all UK NCRI members from its Cancer Research Database (CaRD). The database only includes entries where funding can be directly attributed to a set of clearly defined research objectives. This means that the CaRD only contains information on all direct research funding (project, programme, fellowship, unit and institute) financed by NCRI Member organizations, for which an abstract has been submitted and where the project is active in any given financial year (April - March). Examples of funding that are currently outside the scope of CaRD are infrastructure, meeting grants and research management support."
Breakthrough (UK)	The ICRP database includes all Breakthrough Breast Cancer\'s research spend reported through its Annual Reports & Accounts. There is some variance due to different reporting periods (1 April snapshot versus full financial year) meaning that some research spend that is already committed may not be included in the ICRP figures. Expenditure on non-research charitable activities and management support costs are excluded from the NCRI, and by extension, the ICRP dataset. For further information on Breakthrough\'s research please visit www.breakthroughresearch.org.uk or email research@breakthrough.org.uk
CR-UK (UK)	The ICRP database includes around 70% of Cancer Research UK\'s direct research spend per financial year as reported through its Annual Reports & Accounts. There is some variance due to different reporting periods meaning that some direct research spend that is planned for allocation will not be included in the ICRP figures. Expenditure on vital research services, technology transfer, meeting grants, research management support and infrastructure to support Cancer Research UK\'s activities is excluded from the NCRI, and by extension, the ICRP dataset.
Department of Health (UK)	There will always be some variance between the figures available on ICRP and the figures reported publicly by DH. There are two reasons for this. Firstly, there is variance due to different reporting periods (1 April snapshot of ICRP versus full financial year reporting by DH). Secondly, the Department\'s National Institute for Health Research (NIHR) encompasses various expenditure on NHS infrastructure for research relevant to cancer that is not in a format that it is possible to capture for ICRP.
Macmillan (UK)	The ICRP database represents about 90% of Macmillan Cancer Support\'s direct research spend per financial year. There is some variance due to different reporting periods meaning that some direct research spend that is planned for allocation will not be included in the ICRP figures. Expenditure on research management support and infrastructure to support Macmillan Cancer Support\'s activities is excluded from the NCRI, and by extension, the ICRP dataset.
Scottish Government Health Directorates (UK)	Scottish Government is committed to improve the health of the Scottish population and the Chief Scientist\'s Office (CSO) funds across a broad range of relevant disease areas. Overall, 75% of the CSO spend is committed to research infrastructure in NHS Scotland. This and much other research expenditure is therefore outside the NCRI remit and, by extension, the ICRP dataset.

Canadian organizations who are part of the CCRA
Partner	Caveat
CCRA	Caveats/limitations specific to Canadian Cancer Research Alliance organizations can be accessed here.

Difference	Detail	Impact on investment figures
Not all CCRS participating organizations are included in the ICRP.	For the period 2005–2021, CCRA submitted data to the ICRP for 35 organizations and three now defunct multi-funded initiatives (CBCRA, CPCRI, and CTCRI). Note that the Canadian Breast Cancer Research Foundation merged operations with the Canadian Cancer Society in February 2017 and Prostate Cancer Canada merged in 2020. Importantly, Alberta Innovates did not report any research projects for 2020 and 2021 due to staffing constraints. Projects within the CCRS total 30,218, of which 24,129 were reported to ICRP.	Moderate for years 2020 and 2021
Not all CCRS projects are included in the ICRP.	“Related support” grants (i.e., travel awards, workshops/symposia, LOIs, etc.) are not submitted to ICRP, but are included in reports released by CCRA. In addition, equipment/infrastructure grants through the Canada Foundation for Innovation and for other funders where the cancer relevance weighting is less than 80% are not reported to the ICRP, but are included in CCRA reports. Any project with cancer relevance of less than 20% is also not reported to the ICRP.	Moderate
Co-funded projects are listed by the administering organization.	Projects that are co-funded appear under the administering organization and are not duplicated per funder. Within CCRA reports, however, investments are reported by the actual funders.	Minor
ICRP uses a different approach to calculating annual project investment.	CCRA provides ICRP with the project budget (adjusted for cancer relevance) and start and end dates. A pro-rated calculation is used to derive annual investment. Within the CCRS, prorated calculations on the basis of annual project amounts (where those data are available) are used to calculate the annual investment.	Minor
ICRP uses different site coding conventions.	The cancer site/type codes used within the CCRS are different from ICRP site codes so results by site will vary in some instances.	Minor
ICRP has technical limitations.	ICRP has a technical limit of 12 site codes and 8 CSO codes and this requires truncation for a couple of large-scale projects within the CCRS.	Very minor
CCRA provides less descriptive information about its projects to ICRP.	Lay abstracts are submitted by CCRA to the ICRP in lieu of technical abstracts and in their language of origin. For projects without lay abstracts (and there are a significant number of these), only titles are provided. An English translation is provided alongside all French project titles to facilitate use of the search engine.	No impact on investment figures, but limits full functionality of search engine especially for organizations that do not collect/report lay abstracts.